SCHEMBL11913693

SCHEMBL11913693

Cc1ccc(/C=C2\SC(=S)N(CCC(=O)Nc3ccccc3O)C2=O)cc1

nearest known ligand 0.75

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 11/20 0.75
▸ MEN1 O00255 8/20 0.75
▸ MAPT P10636 4/20 0.75
▸ MAPK1 P28482 2/20 0.75
▸ HTT P42858 1/20 0.75
▸ SMN1; SMN2 Q16637 1/20 0.75
▸ DDX3X O00571 4/20 0.73
▸ POLB P06746 1/20 0.73
▸ PSMD14 O00487 1/20 0.66
▸ NPC1 O15118 1/20 0.66
▸ RAB9A P51151 1/20 0.66
▸ XBP1 P17861 1/20 0.65
▸ GPR35 Q9HC97 1/20 0.65
▸ ALDH1A1 P00352 1/20 0.65
▸ NCOA3 Q9Y6Q9 1/20 0.65
▸ NPSR1 Q6W5P4 1/20 0.64
▸ RXFP1 Q9HBX9 1/20 0.64
▸ CACNA1B Q00975 1/20 0.64
▸ APBA1 Q02410 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11913685 0.92 MEN1 (0.88) KMT2AMEN1MAPTMAPK1HTT
SCHEMBL1656575 0.90 DDX3X (0.80) KMT2AMEN1MAPTMAPK1HTT
SCHEMBL1656574 0.90 DDX3X (0.80) KMT2AMEN1MAPTMAPK1HTT
SCHEMBL1656571 0.90 DDX3X (0.80) KMT2AMEN1MAPTMAPK1HTT
SCHEMBL12008782 0.89 KMT2A (0.90) KMT2AMEN1MAPTDDX3XPOLB
SCHEMBL11913694 0.87 KMT2A (0.68) KMT2AMEN1MAPTMAPK1HTT
SCHEMBL12692505 0.86 KMT2A (0.92) KMT2AMEN1MAPTMAPK1POLB
SCHEMBL1655846 0.85 DDX3X (0.88) KMT2AMEN1MAPTMAPK1HTT
SCHEMBL1655849 0.85 DDX3X (0.88) KMT2AMEN1MAPTMAPK1HTT
SCHEMBL1655845 0.85 DDX3X (0.88) KMT2AMEN1MAPTMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120202814-A1 COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF UNIVERSITÀ DEGLI STUDI DI SIENA (IT) 2012-08-09 — — US disclosed
US-20120202814-A1 COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF UNIVERSITÀ DEGLI STUDI DI SIENA (IT) 2012-08-09 — — US disclosed
WO-2011039735-A2 COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF CONSIGLIO NAZIONALE DELLE RICERCHE (IT) 2011-04-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202814-A1 COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF DDX3X, DDX21, DDX39B KMT2A 2610/4885MEN1 1855/4885MAPT 4074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback